Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is i...
Leadership
Balkrishan Gill Ph.D.
Executive Co-Chairman of the Board
Steven A. Ledger
CEO & Director
J. Milton Harris Ph.D.Founder
Co-Founder, Director Emeritus & Chair of Scientific Advisory Board
